A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
Iambic Therapeutics, Inc
Stemline Therapeutics, Inc.
NRG Oncology
Mayo Clinic
Weill Medical College of Cornell University
UMC Utrecht
City of Hope Medical Center
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
Adela, Inc
Hoosier Cancer Research Network
Sunnybrook Health Sciences Centre
University of Rochester
Mayo Clinic
Beijing Biostar Pharmaceuticals Co., Ltd.
Peking University Cancer Hospital & Institute
Weill Medical College of Cornell University
SWOG Cancer Research Network
Jonsson Comprehensive Cancer Center
Columbia University
Algemeen Ziekenhuis Maria Middelares
Fudan University
University of Sydney
Peking Union Medical College Hospital
Second Affiliated Hospital of Guangzhou Medical University
Samsung Medical Center
A.O.U. Città della Salute e della Scienza
Shanghai Yunying Medical Technology